ADC TOXICITY ATLAS
Payloads & linkers
Payload · Microtubule (other)

Eribulin

Tubulin inhibitor

C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O
Physicochemistry

Properties

MW
729.9 Da
XLogP3
1.1
logD₇.₄
-
TPSA
146 Ų
pKa
-
Charge pH 7.4
+1
H-bond donors
2
H-bond acceptors
12
Bystander
Yes
PubChem CID
11354606
Bioactivity
ADCdb reports ADC cytotoxicity IC50: IGROV-1 (ovarian) 0.01 pM / 0.02 nM; NCI-H2110 (lung) 0.74 pM / 0.42 nM; Caov-3 (ovarian) 0.43 nM; OVCAR-3 (ovarian) 0.75 nM (FOLR1-dependent, sub-nM to pM potency).
1 agent

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
Farletuzumab ecteribulinFOLR1
9
20.8
45
27
33.3
23
6.7
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed